NASDAQ:SEER Seer (SEER) Stock Price, News & Analysis $1.69 -0.03 (-1.74%) Closing price 05/18/2026 04:00 PM EasternExtended Trading$1.68 0.00 (-0.30%) As of 07:36 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Seer Stock (NASDAQ:SEER) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Seer alerts:Sign Up Key Stats Today's Range$1.68▼$1.7550-Day Range$1.66▼$2.0552-Week Range$1.65▼$2.41Volume319,191 shsAverage Volume411,401 shsMarket Capitalization$95.35 millionP/E RatioN/ADividend YieldN/APrice Target$4.00Consensus RatingBuy Company Overview Seer, Inc. is a life sciences company focused on pioneering next-generation proteomics, the large-scale study of proteins and their functions in complex biological systems. By leveraging proprietary nanoparticle-based technology, Seer’s platform enables high-throughput, unbiased protein analysis from biological samples, addressing a critical bottleneck in drug discovery, biomarker research and precision medicine. The company’s flagship Proteograph Product Suite combines engineered nanoparticle assays with advanced mass spectrometry and bioinformatics pipelines to deliver deep proteomic coverage in a scalable workflow. Researchers can simultaneously capture and quantify thousands of proteins from small volumes of blood, plasma or other biospecimens, providing insights into disease pathways, target validation and therapeutic response that were previously inaccessible through traditional proteomic approaches. Founded in 2018 and headquartered in Redwood City, California, Seer has rapidly expanded its reach to serve pharmaceutical and biotechnology companies, academic research centers and clinical laboratories worldwide. Since going public on the Nasdaq in mid-2021, the company has continued to invest in R&D to enhance its product capabilities, drive assay reproducibility and broaden applications across immuno-oncology, neurology, cardiovascular disease and other therapeutic areas. Guided by a management team with deep expertise in proteomics, genomics, instrumentation and data analytics, Seer aims to democratize access to comprehensive protein measurement at scale. Its ongoing collaborations with leading life sciences organizations underscore the growing demand for proteomic insights in advancing drug development, enabling personalized diagnostics and unlocking new understandings of human health and disease.AI Generated. May Contain Errors. Read More Seer Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks66th Percentile Overall ScoreSEER MarketRank™: Seer scored higher than 66% of companies evaluated by MarketBeat, and ranked 296th out of 859 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.1 / 5Analyst RatingBuy Consensus RatingSeer has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Upside PotentialSeer has a consensus price target of $4.00, representing about 136.7% upside from its current price of $1.69.Amount of Analyst CoverageSeer has only been the subject of 3 research reports in the past 90 days.Read more about Seer's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Seer is -1.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Seer is -1.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSeer has a P/B Ratio of 0.37. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Seer's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.85% of the float of Seer has been sold short.Short Interest Ratio / Days to CoverSeer has a short interest ratio ("days to cover") of 1.03, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Seer has recently decreased by 1.15%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSeer does not currently pay a dividend.Dividend GrowthSeer does not have a long track record of dividend growth. News and Social Media1.8 / 5News Sentiment-0.09 News SentimentSeer has a news sentiment score of -0.09. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.59 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 15 news articles for Seer this week, compared to 5 articles on an average week.Search Interest1 people have searched for SEER on MarketBeat in the last 30 days. Company Ownership1.1 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Seer insiders have not sold or bought any company stock.Percentage Held by Insiders11.28% of the stock of Seer is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions75.20% of the stock of Seer is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Seer's insider trading history. Receive SEER Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Seer and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SEER Stock News HeadlinesGhana’s first female president?: Prophet Seer 1 issues major prophecy for NDC’s Jomoro MP Dorcas Toffey44 minutes ago | msn.comSeer, Inc. Q1 2026 Earnings Call SummaryMay 15, 2026 | finance.yahoo.comIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of the world's oil passing through that corridor, crude has already crossed $100 per barrel. History shows gold surged 571% during the 1973 oil crisis and 425% in 1979. Today, the U.S. holds 8,133 tonnes of gold valued on the books at $42.22 per ounce - while gold trades above $5,000. American Alternative Assets has released The Great Gold Reset report detailing what this gap could mean for investors.May 19 at 1:00 AM | American Alternative (Ad)Seer Earnings Call Balances Near-Term Pain, Long-Term PromiseMay 14, 2026 | tipranks.comThe Radoff-JEC Group Submits its Third Non-Binding Proposal to Acquire Seer, Inc.May 14, 2026 | finance.yahoo.comSeer (SEER) Q1 2026 Earnings Call TranscriptMay 14, 2026 | finance.yahoo.comSeer (SEER) price target increased by 33.33% to 4.08May 14, 2026 | msn.comFull Transcript: Seer Q1 2026 Earnings CallMay 14, 2026 | finance.yahoo.comSee More Headlines SEER Stock Analysis - Frequently Asked Questions How have SEER shares performed this year? Seer's stock was trading at $1.83 at the beginning of the year. Since then, SEER stock has decreased by 7.7% and is now trading at $1.69. How were Seer's earnings last quarter? Seer, Inc. (NASDAQ:SEER) issued its quarterly earnings data on Wednesday, May, 13th. The company reported ($0.30) EPS for the quarter, missing the consensus estimate of ($0.30) by $0.01. The business earned $2.79 million during the quarter, compared to analyst estimates of $3.60 million. Seer had a negative net margin of 464.78% and a negative trailing twelve-month return on equity of 26.58%. Read the conference call transcript. When did Seer IPO? Seer (SEER) raised $157 million in an initial public offering on Friday, December 4th 2020. The company issued 9,210,527 shares at $16.00-$18.00 per share. J.P. Morgan, Morgan Stanley, BofA Securities and Cowen served as the underwriters for the IPO. Who are Seer's major shareholders? Seer's top institutional investors include Siren L.L.C. (4.36%), Renaissance Technologies LLC (1.73%), Dimensional Fund Advisors LP (0.39%) and Rangeley Capital LLC (0.33%). Insiders that own company stock include Omid Farokhzad, David R Horn, Elona Kogan, Elona Esq Kogan and Dipchand Nishar. View institutional ownership trends. How do I buy shares of Seer? Shares of SEER stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Seer own? Based on aggregate information from My MarketBeat watchlists, some other companies that Seer investors own include fuboTV (FUBO), NIO (NIO), Advanced Micro Devices (AMD), Peloton Interactive (PTON), Tesla (TSLA) and Lemonade (LMND). Company Calendar Last Earnings5/13/2026Today5/19/2026Next Earnings (Estimated)8/05/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (37m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 SEER's financial health is in the Red zone, according to TradeSmith. SEER has been in this zone for over 37 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - BIOMED/GENE Sub-IndustryMeasuring And Control Equipment Current SymbolNASDAQ:SEER CIK1726445 Webwww.seer.bio Phone650-453-0000FaxN/AEmployees160Year Founded2017Price Target and Rating Average Price Target for Seer$4.00 High Price Target$4.00 Low Price Target$4.00 Potential Upside/Downside+136.7%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)($1.24) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$73.60 million Net Margins-464.78% Pretax Margin-464.06% Return on Equity-26.58% Return on Assets-23.51% Debt Debt-to-Equity RatioN/A Current Ratio17.73 Quick Ratio16.94 Sales & Book Value Annual Sales$16.58 million Price / Sales5.75 Cash FlowN/A Price / Cash FlowN/A Book Value$4.61 per share Price / Book0.37Miscellaneous Outstanding Shares56,420,000Free Float50,057,000Market Cap$95.35 million OptionableOptionable Beta1.63 Social Links (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free Report This page (NASDAQ:SEER) was last updated on 5/19/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredElon’s AI supercomputer just went live. Here’s my #1 stock.Is Elon about to trigger another 315X opportunity? Elon gave Tesla investors the chance to make more than 3...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Seer, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Seer With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
